Highlights d Crystal structure of human a 2C AR in complex with RS79948 is solved d A specific loosened helix at the top of TM4 in a 2C AR is involved in receptor activation d Extracellular regions play a role in determining a 2 adrenergic subtype selectivity SUMMARY Adrenergic G-protein-coupled receptors (GPCRs) mediate different cellular signaling pathways in the presence of endogenous catecholamines and play important roles in both physiological and pathological conditions. Extensive studies have been carried out to investigate the structure and function of b adrenergic receptors (bARs). However, the structure of a adrenergic receptors (aARs) remains to be determined. Here, we report the structure of the human a 2C adrenergic receptor (a 2C AR) with the non-selective antagonist, RS79948, at 2.8 Å . Our structure, mutations, modeling, and functional experiments indicate that a a 2C AR-specific D206 ECL2 -R409 ECL3 -Y405 6.58 network plays a role in determining a 2 adrenergic subtype selectivity. Furthermore, our results show that a specific loosened helix at the top of TM4 in a 2C AR is involved in receptor activation. Together, our structure of human a 2C AR-RS79948 provides key insight into the mechanism underlying the a 2 adrenergic receptor activation and subtype selectivity.
In Brief
Chen et al. report the crystal structure of human a 2C AR and the functional experimental results, which indicate that extracellular regions determine a 2 adrenergic subtype selectivity. The structural and functional results provide the molecular explanation for a 2C AR selective ligands and insights to understand GPCR subtype selectivity.
INTRODUCTION
Adrenergic receptors can be classified into two subgroups: aARs and bARs (Ahlquist, 1948 (Ahlquist, , 1962 (Ahlquist, , 1967 , with the former further divided into a 1 ARs and a 2 ARs. a 1 ARs, a 2 ARs, and bARs trigger G q , G i , and G s proteins, respectively, when activated by two main endogenous ligands, epinephrine and norepinephrine. Activation of bARs results in the increase of heart rate, contractile force, and the relaxation of smooth muscle, while activation of a 1 ARs leads to vasoconstriction of vascular smooth muscle. a 2 ARs, as presynaptic inhibitory receptors, are important for regulating catecholamine signaling (B€ ucheler et al., 2002; MacDonald et al., 1997) . In humans, a 2 ARs are divided further into three subtypes: a 2A AR, a 2B AR, and a 2C AR. a 2A AR and a 2C AR both regulate the release of norepinephrine but at high and low stimulation frequencies, respectively (Hein et al., 1999) . a 2C AR possesses some unique properties. It displays dominant intracellular distribution in fibroblasts and vascular smooth muscle cells, compared with strong plasma membrane localization in neuronal or endocrine cells (Angelotti et al., 2010; Daunt et al., 1997; Filipeanu et al., 2011; Hurt et al., 2000) . Interestingly, a 2C AR is sensitive to decreased environmental temperature and it is transported to the cell surface during exposure to temperatures down to 28-30 C (Chotani and Flavahan, 2011; Chotani et al., 1999; Filipeanu et al., 2011 Filipeanu et al., , 2015 Honda et al., 2007; Jeyaraj et al., 2001) . This sensitivity explains a 2C AR's role in Raynaud's syndrome, a disease associated with cold exposure (Chotani et al., 2000; Filipeanu, 2015) .
Although the three a 2 AR subtypes differ considerably in their tissue distribution and physiological roles, they are highly homologous in the trans-membrane region and thus share most agonists and antagonists, limiting receptor-specific research to genetic modification in animals (Brede et al., 2002 (Brede et al., , 2003 Hein et al., 1999; Kable et al., 2000; Moura et al., 2006) and in vitro investigations in cell lines. Clearly, the ability to selectively target the a 2 AR subtypes would have important benefits on further in vivo study for a 2 ARs. Unfortunately, the source of this subtype selectivity is not well understood. To this end, we solved the crystal structure of human a 2C AR in complex with RS79948, a non-selective antagonist of a 2 ARs. Based on the solved structure, two selective antagonists, JP1302 and OPC-28326, were docked into a 2C AR, and, supported by mutagenesis, modeling, functional assays, and comparison with other aminergic receptors, we are able to provide key insight into the subtype selectivity of a 2 ARs.
RESULTS

a 2C AR Displays a Prototypical Class-A G-Protein-Coupled Receptor Atomic Structure
We carried out structural studies using an engineered human a 2C AR construct with modifications as detailed in Figure S1 . Proteins were purified and crystallized in complex with RS79948. The binding affinity of RS79948 with this engineered a 2C AR protein was comparable to that with the wild-type receptor (Figures S1E and S1F). The crystal structure of the a 2C AR-RS79948 complex, which was determined at 2.8-Å resolution (Table S1) , was found to exhibit a canonical class A G-protein-coupled receptor (GPCR) architecture, including a seven-transmembrane helical bundle (TM I-VII) linked by three extracellular (ECL1-3) and three intracellular (ICL1-3) loops, and a four-residue truncated helix VIII (Figure 1 ). The a 2C AR-RS79948 complex displayed the typical inactive state structure of class A GPCRs, i.e., the intracellular helical arrangements and microswitches were consistent with the b 2 AR structure in an inactive-like state (PDB: 2RH1, 3SN6) (Cherezov et al., 2007; Rasmussen et al., 2011) ( Figure S2 ). a 2C AR Shows a Highly Hydrophobic Pocket RS79948 is a non-selective high-affinity a 2 AR antagonist belonging to non-imidazoline class and forms a conserved salt bridge with the carboxylate group of D131 3.32 in pocket (Figure 2A) . Electron density of RS79948 and surrounding residues at this area are included ( Figure S3 ). Besides the polar binding with D131 3.32 , RS79948 is surrounded by seven aromatic residues on TM6 and TM7, and L204 45.52 at the center of the pocket forming the hydrophobic environment of the pocket (Figure 2A ). RS79948 forms cation-p and p-p interactions with F398 6.51 and another cation-p with F423 7.39 ( Figure 2B ). a 2C AR L204 45.52 I has no effect on UK14,304 but decreases the potency of RS79948, suggesting L204 45.52 plays a role in determining subtype selectivity ( Figure 2B ). Furthermore, L128 3.29 , as part of the hydrophobic barrier, is a selective ligand binding site since L128 3.29 A or L128 3.29 W significantly attenuates the antagonism of RS79948, while it has no effect on UK14, 304 (Figures 2B and 2C) .
Structure Comparison between a 2C AR and Other Aminergic Receptors
Next, we compared the pocket shapes of our solved structure, the ligand positions, and the features of the extracellular parts to other aminergic receptors (Cherezov et al., 2007; Chien et al., 2010; Haga et al., 2012; Ishchenko et al., 2017; Kruse et al., 2012; Peng et al., 2018; Shimamura et al., 2011; Thal et al., 2016; Wang et al., 2017 Wang et al., , 2018 Warne et al., 2012; Yin et al., 2018) ( Figure 3 ). RS79948 in a 2C AR occupied a relatively shallow position ( Figure S4 ), suggesting that a 2C AR antagonists may be more impacted by extracellular parts than most of the other aminergic receptors. Likewise, pocket shapes differed especially between subfamilies, while their volumes were comparable, likely due to the conservation of aminergic GPCRs ( Figure S4 ). ECLs play an important role during receptor-ligand association and ligand binding and possess much more diversity than transmembrane regions among solved aminergic receptors ( Figure 3 ). In our a 2C AR structure, two disulfide bonds exist in the extracellular region of a 2C AR: C124 3.25 -C202 45.50 and C408 6.61 -C412 ECL3 . The former, constraining ECL2 to TM3, is conserved in most GPCRs and disruption of this disulfide bond often impairs agonist binding affinity. Moreover, the C 3.25 -C 45.50 separates ECL2 into two segments. The segment between C 45.50 and TM5 is directly involved in ligand binding, like L204 45.52 in a 2C AR ( Figure 2 ). Another segment between TM4 and C 45.50 is more diverse and flexible. Notably, even a small change in its length and flexibility can impact the activation of a 2C AR.
A difference at the top of TM4 in a 2C AR, compared to other aminergic receptors, is the loosened helix. This is likely caused by the existence of two prolines PP (185 4.59 , 186 4.60 ). The P185L mutation on a 2C AR was predicted to regain the helical structure at the top of TM4 considering the similar sequence and typical helix structure in b 2 AR-TM4 ( Figures S5A and S5B ), which may shorten ECL2 and decrease its flexibility. The P185L mutation attenuated the potency of the two endogenous agonists, norepinephrine and epinephrine ( Figure S5C ), suggesting that appropriate flexibility of ECL2 may be necessary for GPCR activation. However, the P185L mutation seemed to have much less effect on a 2 -agonists, such as clonidine and dexmedetomidine ( Figure S5 ), which had no hydroxyl group on the benzene ring and thus had less interactions with TM5 linked with ECL2. This indicated that the loosened helix on TM4 may be specifically involved in the receptor activation triggered by norepinephrine and epinephrine.
Despite the low sequence identity among aARs and bARs, they all target endogenous ligands epinephrine and norepinephrine. When comparing a 2C AR with other solved aminergic receptors, we found three reasonable similar structures: a 2A AR (root-mean-square deviation [RMSD]: 0.971), b 1 AR (PDB: 5A8E; Sato et al., 2015 ; RMSD: 1.389), and b 2 AR (PDB: 2RH1; RMSD: 1.343). Among the 12 defined aminergic orthosteric binding sites (OBSs) (3.32, 3.33, 3.36, 45.52, 5.42, 5.46, 6.48, 6.51, 6.52, 6.55, 7.39, and 7.43) (Michino et al., 2015) , 8 sites are conserved in adrenergic receptors ( Figure S6A ). D3.32, S5.42, S5.46, Y7.43, forming H-bonds with epinephrine (in b 2 AR-epinephrine structure; PDB: 4LDO) (Ring et al., 2013) , are identical in the nine adrenergic receptors, despite specific residues at 6.55 and 7.39 forming additional H-bonds in bARs ( Figure S6B ). In the a 2C AR-epinephrine docking model, Y6.55 forms H-bond with epinephrine, similar to N6.55 in b 2 AR (4LDO).
Subtype Adrenergic Selectivity Can Be Achieved by Targeting Extracellular Loops
When we further compared the structure of a 2C AR-RS79948 and a 2A AR-RS79948 (PDB: 6KUX) (L Qu, Q.Z., Y.X., Y.G., X.C., G.W.H., Z.J.L., R.C.S., G.Z., D.W., and S.Z., unpublished data), we found that RS79948 interacts with almost the same binding sites, except for the residue at 45.52 which is L in a 2C AR and I in a 2A AR ( Figure S7A ). Also, OPC-28326, an a 2C AR selective antagonist with about 40-fold lower affinity on a 2A AR, docked into both a 2C AR and a 2A AR bound to similar orthosteric pocket sites, ignoring some unshown extracellular residues ( Figure S7B ). This finding supports the conclusion that subtype selectivity does not come from the orthosteric pockets. The ECL3 region 408 CREAC 412 in a 2C AR was found differing from that in a 2A AR, creating a kink in the loop that orients R409 ECL3 to interact with D206 ECL2 and another unique residue that we discuss below.
To reveal the molecular basis in the orthosteric pocket for which JP1302 selectively binds a 2C AR rather than a 2A AR, we performed molecular-docking-guided mutagenesis study. JP1302 competitively binds the orthosteric pocket of a 2C AR (Figures S8A and S8B). There are two positively charged amine groups on JP1302 that may interact with D131 3.32 . To verify which nitrogen atom was involved in this interaction, a new molecule named TC1515 was synthesized with the 1-methylpiperazine group of JP1302 changed to morpholine and TC1515 did not exhibit the antagonism on a 2C AR ( Figures S8C and S8D ). This result is consistent with one of the molecule docking pose of JP1302 (Figures S8E and S8F) . This model explains why L128 3.29 A attenuated the potency of RS79948 but does not affect JP1302, while another mutation L128 3.29 W with larger side chain slightly increases the potency of JP1302 ( Figure S8E ; Table S2 ). Notably, F419 7.35 W enhances the binding by, perhaps, stronger T-shape p-p interaction. More importantly, the positively charged amine group in the 2,3-benzoquinoline of JP1302 displays a salt bridge with D206 ECL2 and cation-p interaction with Y405 6.58 , a unique residue among aminergic receptors.
Given the unique configuration of the extracellular domains of a 2C AR, we hypothesized that ligand subtype selectivity may be due to these differences. a 2C AR has a specialized interaction Figure S3 and Table S1 . (B) Schematic representation of the interactions between a 2C AR and RS79948. The salt bridge is shown as green dashed line, and p-p interaction and cation-p interaction are shown as red dashed lines. (C) Mutation analysis of binding pocket key residues by cAMP assay. The potency of UK14,304 and RS79948 as determined by comparison of the negative logarithm of the EC 50 (pEC 50 ) values (data are mean ± SEM; n R 3). Statistical analyses of RS79948 were not performed on L204A, W395A, F419A, F423A, F423W, and Y427A as they show inconsistent response to UK14,304 compared to wild-type (WT) a 2C AR. See Table S2. network formed by D206 ECL2 , R409 ECL3 , and Y405 6.58 that does not exist in a 2A AR ( Figure 4A ). Each of the three mutations and the triple mutation had no effect on RS79948 ( Figure 4B ). Although among the three point mutations, only Y405T slightly reduced the potency of JP1302, the triple mutation abolished JP1302's and OPC-28326's effect, implying that these sites and their network may be critical to the ligands specific to this subtype. In addition, the a 2A AR structure-based model with the complementary side chains of Y98 ECL1 , E189 ECL2 , and R405 7.32 showed that there may be a different interaction network in a 2A AR formed by Y98 ECL1 , R187 ECL2 , E189 ECL2 , and R405 7.32 acting as a lid that covers the entrance of the ligand binding pocket ( Figure 4C ). This may block out big molecules like JP1302 and OPC-28326 that conversely will settle into the a 2C AR pocket through an unimpeded entrance. Thus, we were able to design and build an engineered a 2A AR to restore JP1302/OPC-28326 antagonism on it.
We hypothesized that a a 2A AR chimera, with the a 2A AR ''lid'' disabled (R405 7.32 G) and the a 2C AR unique network added (the ECL3 nearby part of a 2A AR, T397 6.58 -P404 ECL3 , replaced with the corresponding part of a 2C AR, Y405 6.58 -P415 7.31 ), may allow JP1302 and OPC-28326 to settle in the a 2A AR chimera pocket ( Figure 4D ). The additional mutation, K144A, was introduced in to remove interference of high-concentration-agonist-induced G s signaling, which was demonstrated in a 2A AR (L Qu, Q.Z., Y.X., Y.G., X.C., G.W.H., Z.J.L., R.C.S., G.Z., D.W., and S.Z., unpublished data). The functional assay showed that JP1302 and OPC-28326 displayed good antagonism effects on the a 2A ARchimera. Moreover, a 2A AR-R405G and chimera-G408R (both with K144A) had partial rescue compared with a 2A AR-chimera. This experiment supports our hypothesis that the ''lid'' in the a 2A AR pocket entrance shut out JP1302 and OPC-28326 and that the network at the a 2C AR pocket edge interacted with the two selective antagonists (Figures 4E and 4F ).
DISCUSSION
In this study, we solved the crystal structure of human a 2C AR-RS79948, which provides some insight for understanding receptor-ligand interaction and subtype selectivity. The differences between a and b adrenergic receptors were identified by distinct potency of agonists (Ahlquist, 1948) . Based on a 2C AR-RS79948 atomic structure, we docked a native ligand epinephrine into the pocket and investigated the similarity between aARs and bARs for their recognition to the same endogenous ligands. Besides, earlier functional studies showed that the position 7.39, which is F in aARs and N in bARs, may play a critical role in determining the selectivity between a and b adrenergic receptors. N312 7.39 Q and N312 7.39 T mutants in b 2 AR increased the binding affinity of a 2 -antagonists yohimbine and para-aminoclodine (Suryanar-ayana and Kobilka, 1993), while F412 7.39 N in a 2A AR significantly increased the affinity of dihydroalprenolol, a b 2 -antagonist (Suryanarayana et al., 1991) . The property and proper size of N7.39 is important for b-selective ligands with ethanolamine backbones and bigger substitutions on the amine, from isopropyl (isoprenaline, alprenolol) to aromatic rings (salmeterol, carvedilol). See Figures S7 and S8. (A) The unique interaction network formed by D206 ECL2 , R409 ECL3 , and Y405 6.58 in a 2C AR is displayed as a black dashed line. (B) The potency comparison of RS79948, JP1302, and OPC-28326 on a 2C AR WT and mutations. The results of cAMP assay are shown as pEC 50 values (data are mean ± SEM; n R 3). The pEC 50 values of JP1302 and OPC-28326 on D206A/R409A/Y405T were estimated at >5 mM due to a lack of response and nonconvergence of the data to nonlinear regression analysis. (C) Interaction network formed by Y98 ECL1 , R187 ECL2 , E189 ECL2 , and R405 7.32 in the a 2A AR model with side chains of Y98 ECL1 , E189 ECL2 , and R405 7.32 computed based on a 2A AR structure. (D) Predicted structure of a 2A AR chimera with T397-R405 replaced by a 2C AR Y405-G416, which were renumbered as Y397-G408 and are shown in wheat. (E and F) a 2A AR R405G, a 2A AR chimera, and chimera G408R (all with additional K144A) allowed JP1302 (E) and OPC-28326 (F) to display antagonism on clonidine (10 mM)-induced cAMP inhibition compared to a 2A AR WT. Data are shown as mean ± SEM with three independent experiments performed in triplicate.
In bARs, H-bonds were formed between the residues S5.42, S5.46, and the meta hydroxyl, para hydroxyl on the benzene ring of most agonists. These bindings were found to be necessary for the receptor activation (Sato et al., 1999) . Typical a 1 -agonists such as phenylephrine, xymetazoline, and A61603, only contained a meta hydroxyl on the benzene ring, which was supposed to interact with S5.42 (Hwa and Perez, 1996) . It was suggested that the polar interaction between agonists and TM5 was important for activation of adrenergic receptors. Notably, a 2 agonists did possess the hydroxyl groups on the benzene ring, but the a 2 receptor activation was not affected, suggesting that additional mechanism may underlie its activation.
Interestingly, our structure of human a 2C AR-RS79948 indicated that a loosened helix at the top of TM4 specifically existed in a 2 ARs, which was involved in regulating the ligand binding and receptor activation. The helix structure was hypothesized to be regained by P185L of a 2C AR. Our functional results showed that the potency of epinephrine and norepinephrine was significantly reduced, while a 2 -agonists clonidine and dexmedetomidine, without the hydroxyl group, showed no or slight potency reduction on a 2C AR-P185L. We reasoned that hydroxyl groups of epinephrine and norepinephrine formed H-bond with TM5, and the change of loosened helix of TM4 induced a change of ECL2, which was directly involved in ligand binding. The loosened helix at TM4 of a 2 ARs is an elaborate change in evolution of GPCR and plays a specific role in the receptor activation of a 2 ARs.
Moreover, despite the highly conserved pocket, the molecular basis of selectivity between a 2C AR and a 2A AR was revealed by docking model, mutations, and the a 2A AR-chimera. The triple mutation D206A/R409A/Y405T abolished the function of JP1302 and OPC-28326 while it had no effect on nonselective UK14,304 and RS79948, suggesting that the network found in the structure was crucial for a 2C AR selectivity. In the a 2A ARchimera protein, we reliably reproduced the antagonism of a 2C AR selective antagonists on a 2A AR by removing the a 2A ARspecific ''lid'' and adding a 2C AR-specific D206 ECL2 -R409 ECL3 -Y405 6.58 network. Our structural and functional results provided molecular foundation for a 2C AR selective ligands beneficial to in vivo subtype functional study and new insights to understanding GPCR subtype selectivity.
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STAR+METHODS KEY RESOURCES
Engineering of Human ADRA2C for Structure Determination
The human WT ADRA2C (UniProtKB-P18825) gene was synthesized using GenScript with flanking restriction sites AscI at the 5 0 end and FseI at the 3 0 end. The expression vector was a modified pFastBac1 vector (Invitrogen) containing an expression cassette with an HA signal sequence followed by a FLAG tag at the N terminus and a PreScission protease site followed by a 10xHis tag at the C terminus. A DNA fragment corresponding to residues 29-458 of ADRA2C_HUMAN was cloned into the site between AscI and FseI. ICL3 region (242-371) was replaced by a PGS fusion protein that was generated by the 196-amino-acid coding sequence of P. abysii glycogen synthase (PDB accession 2BFW). Three mutations I139A, V122W, F391W were introduced into this construct by standard QuickChange PCR protocol.
Protein Expression in sf9 Insect Cell Line
The Bac-to-Bac Baculovirus Expression System (Invitrogen) was used to generate high-titer recombinant baculovirus (> 10 9 viral particles per ml). Recombinant baculovirus was produced by transfecting recombinant bacmids (2.5-5 mg) into Spodoptera frugiperda (Sf9) cells (2.5 mL, density of 10 6 cells per mL) using 5 mL of X-tremeGENE HP DNA Transfection Reagent (Roche) and Transfection Medium (Expression Systems). After 4 days of shaking at 27 C, P0 viral stock ($10 9 virus particles per mL) was harvested as the supernatant of the cell suspension to produce high-titer viral stock. Viral titers were analyzed by flow cytometry on cells stained with gp64-PE antibody (Expression Systems). a 2C AR was expressed by infecting Sf9 cells at a cell density of 2-3x10 6 cells per ml with P1 virus at MOI (multiplicity of infection) of 5. Cells were harvested by centrifugation 48 h post infection and stored at À80 C for future use.
Protein Purification
Thawed insect cell membranes were disrupted in a hypotonic buffer containing 10 mM MgCl 2 , 20 mM KCl, 10 mM HEPES (pH 7.5), and EDTA-free complete protease inhibitor cocktail tablets (Roche). The isolated raw membranes were extensively washed by twice repeated centrifugation in the same hypotonic buffer. Subsequently, soluble and membrane-associated proteins were removed in a high osmotic buffer containing 10 mM MgCl 2 , 20 mM KCl, 1.0 M NaCl, 10 mM HEPES (pH 7.5), and EDTA-free complete protease inhibitor cocktail tablets (three times). Purified membranes were flash-frozen in liquid nitrogen and stored at À80 C for further use.
Purified membranes were thawed at room temperature and incubated in the presence of 50 mM RS79948 and protease inhibitor cocktail at 4 C for 2 h. The membranes were incubated with 2.0 mg/mL iodoacetamide (Sigma) for 30 min and were solubilized in the buffer containing 50 mM HEPES (pH 7.5), 2% (w/v) n-dodecyl-beta-D-maltopyranoside (DDM, Anatrace), 0.2% (w/v) cholesterol hemisuccinate (CHS, Sigma-Aldrich), and 150 mM NaCl, at 4 C for 2.5 h. The solubilized proteins in the supernatants were isolated by high-speed centrifugation (Beckman), and then incubated at 4 C overnight with TALON IMAC resin (Clontech), 500 mM NaCl, and 20 mM imidazole as the final buffer concentration. The resin was washed with 10 column volumes of washing buffer I containing 50 mM HEPES (pH 7.5), 0.1% (w/v) DDM, 0.02% (w/v) CHS, 500 mM NaCl, 10% (v/v) glycerol, 20 mM imidazole, and 50 mM RS79948, and 6 column volumes of washing buffer II containing 50mM HEPES (pH 7.5), 0.02% (w/v) DDM, 0.004% (w/v) CHS, 500 mM NaCl, 10% (v/v) glycerol, and 50 mM RS79948 without imidazole. The protein was eluted using 4 column volumes of elution buffer containing 50 mM HEPES (pH 7.5), 0.02% (w/v) DDM, 0.004% (w/v) CHS, 500 mM NaCl, 10% (v/v) glycerol, 250 Mm imidazole, and 50 mM RS79948. The protein sample was concentrated to 30 mg/mL using a 100 kDa cut-off concentrator (Sartorius) for crystallization trials. The protein yield and monodispersity were measured by aSEC.
Lipidic Cubic Phase Crystallization
The purified a 2C AR protein in complex with RS79948 was screened for crystallization in lipidic cubic phase (LCP) with mixed molten lipid (90% (w/v) monoolein and 10% (w/v) cholesterol) at a protein/lipid ratio of 2:3 (v/v) using a mechanical syringe mixer. LCP crystallization trials were set up using an NT8-LCP crystallization robot (Formulatrix). 96-well glass sandwich plates were incubated at 20 C in an automatic incubator/imager (RockImager 1000, Formulatrix) and imaged. Crystals were obtained in sodium phosphate monobasic (0.1M), HEPES pH6.5-6.9 (0.1M), PEG400 24%-35%, and grew to full size in around 3 day. The crystals were harvested using micromounts (MiTeGen) and flash-frozen in liquid nitrogen.
Data Collection and Structure Determination X-ray diffraction data of a 2C AR RS79948 crystals were collected at beam line BL41XU at SPring-8, Japan, using Eiger 6M detector (X-ray wavelength 1.0000 A ). The data collection strategy was designed based on rastering results as previously described (Cherezov et al., 2009) . Diffraction images were indexed, integrated, and scaled using XDS (Kabsch, 2010) . Initial phases were obtained by the molecular replacement-(MR) method with Phaser (McCoy et al., 2007) . Refinement was carried out with Buster (Smart et al., 2012) iteratively followed by manual examination and adjustments of the refined coordinates in the program COOT (Emsley et al., 2010) using both |Fo|-|Fc| and 2|Fo|-|Fc| electron density maps and omit maps.
Radioligand Binding Assay
Cell membranes from 293F cells expressing wild-type or the engineered a 2C AR receptors were prepared (Ban et al., 2018) . After protein concentration determined using BCA method, aliquoted membrane preparations were stored at À80 C. In saturation binding assay, 20 mg WT type or 10 mg mutant membrane was incubated with serial of concentrations of [Methyl-3 H]-Rauwolscine (Perkin Elmer, Cat.#NET722) in the binding buffer (50 mM HEPES pH 7.4, 5 mM MgCl 2 , 1 mM CaCl 2 , 0.2% BSA) in a total volume of 120 ml. In the competition binding assay, the membrane was incubated with 15 nM [ 3 H]-Rauwolscine in the presence of serial concentration of compounds. The binding reaction mixture was incubated at room temperature in a 96-well plate for 2 h while gently shaking, then was transferred to PEI pre-coated UniFilter GF/B filtration plate and filtered using FilterMate Universal Harvester (Perkin Elmer). The filtration plate was washed quickly three times with ice-cold washing buffer (50 mM HEPES pH 7.4, 500 mM NaCl, 0.1% BSA) then dried at 37 C for 2 h. Scintillation cocktail was added to each well, and radioactivity was counted in MicroBeta Trilux (Perkin Elmer).
Cell Culture and Transfection
To determine GPCR-mediated cAMP production, Promega's split luciferase-based GloSensor cAMP biosensor technology was used. CHO-K1 cells (ATCC) were maintained in F-12 supplemented with 10% FBS and 1% penicillin/streptavidin. When cells reached 70% confluence in a10 cm dish, 1 mg of DNA and 1 mg of GloSensor cAMP DNA were co-transfected by TransIT 2020 (Mirus bio). On the following day, cells were seeded into 384-well white clear-bottom cell culture plates (Greiner) at a density of 10-15,000 cells in 40 mL growth medium per well. The plates were used in assays the next day.
Split Luciferase Biosensor cAMP Assay
After supernatant was removed from 384 well plates, the wells were loaded for 60 min at 37 C with 20 mL of 2 mg/ml Luciferin prepared in HBSS with 0.1% BSA (pH 7.4). All the following steps were carried out at room temperature. To measure agonist activity at a 2C AR, 10 mL 4x test drug solution was added with 15 min incubation before the addition of 10 mL of forskolin (Sigma Aldrich) at a final concentration of 20 mM, followed by the counting of the plate for chemiluminescence after 15 min. To measure antagonist activity, cells were preincubated with test drug for 15 min before a 4x 350nM of UK 14,304 and forskolin at a final concentration of 20 mM were added. Counting was undertaken after 15 min. Chemiluminescence signal was measured on EnVision plate reader (Perkin Elmer).
Epinephrine, JP1302, and OPC-28326 Docking to a 2A AR and a 2C AR We prepared structures of a 2A AR-RS79948 and a 2C AR-RS79948 using Protein Preparation Wizard in Maestro (Schrö dinger LLC, New York, NY, USA). Proteins were pre-processed with default options in ''Import and Process'' panel. For epinephrine, JP1302 and OPC-28326, ionization and conformation states were determined using OPLS3 force field by LigPrep Script in Maestro. The docking of epinephrine, JP1302 and OPC-28326 was performed using the Induced Fit Docking (IFD) program (Schrö dinger LLC, New York, NY, USA) with default parameters and a grid box defined by the molecule RS79948's position in the crystal structure. Finally, we selected the model based on our knowledge (i.e., there must be a salt bridge between ligand and D3.32 in protein) from the IFD results with good scores.
Calculation of Binding Pocket's Volume
The calculation was performed using the program Cavity (Yuan et al., 2011 (Yuan et al., , 2013 in ''large'' mode. The program uses a pretrained model to find atoms that could form a closed pocket. After calculation, Cavity returns a series of pocket pdb files and the vacant files. In the pdb files, the pocket is represented using the least number of closest atoms. In the vacant file, the space inside the pocket is filled with cubic boxes. By counting the number of cubic boxes, the program returns a volume value. The pocket with ligand inside was selected and pocket volume was read from the corresponding vacant file.
Calculation of RMSD
The RMSD values of Ca atoms in transmembrane helices were calculated using UCSF chimera for edge attribute. In total 192 residues were included: BWN 1. 35-57, 2.37-63, 3.22-56, 4.39-63, 5.36-65, 6.33-59, 7.31-55 .
QUANTIFICATION AND STATISTICAL ANALYSIS
The data obtained for individual experimental pEC 50 between WT and mutant a 2C ARs are presented as mean ± SEM (N R 3) in Prism 7 (GraphPad, La Jolla, CA). Statistical analyses comparing pEC 50 between a 2C AR WT and mutants were conducted using two-way ANOVA in Prism 7. K d values for saturation binding assay and K i values for radioligand competition binding assay are presented as mean ± SD (N = 3).
DATA AND CODE AVAILABILITY
The accession number for the coordinates and structure factors of a 2C AR_RS79948 is PDB: 6KUW.
